University of Alabama researchers found blocking Activin A protein halts dyskinesia in Parkinson's patients, potentially improving long-term care.
Researchers at University of Alabama found blocking a protein called Activin A can halt dyskinesia, a form of uncontrollable movements in Parkinson's patients. By preventing Activin A function, they erased the brain's "bad memory" response to L-DOPA treatments, potentially improving long-term Parkinson's care. This approach differs from seeking alternative treatments, aiming to prevent dyskinesia development.
July 08, 2024
3 Articles